The Continued Role of Splenectomy in the Management of Patients with Myelofibrosis

We report, however, that splenectomy remains an effective and safe therapy for those with continued spleen related mechanical symptoms refractory to ruxolitinib and for patients with severe cytopenias that precludes ruxolitinib use.

Source: Clinical Lymphoma, Myeloma and Leukemia - June 7, 2016 Category: Hematology Authors: Daniel Aruch, Myron Schwartz, John Mascarenhas, Marina Kremyanskaya, Carrie Newsom, Ronald Hoffman Tags: Case Report Source Type: research